The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Nateglinide · NATEGLINIDE 120 mg/1 · Tablet · Oral · Dr. Reddy's Laboratories Limited
NDC 55111-0329-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
OAI inspection at a producing facility (24 months) · sole-source market · price up 2% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| American Health Packaging | NATEGLINIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | NATEGLINIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Limited | NATEGLINIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Limited | NATEGLINIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | NATEGLINIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | NATEGLINIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | NATEGLINIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | NATEGLINIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | NATEGLINIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | NATEGLINIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Nateglinide — NDC 55111-0329-01," retrieved September 3, 2026, https://drugdashboards.com/drug/55111032901.
Free to cite with attribution — see how the data is put together.